Clinical trial
TRI102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHA): A Laboratory Classroom Study
NCT02083783 is registered in ClinicalTrials.gov with Tris Pharma, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- TRI102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHA): A Laboratory Classroom Study
- Lead sponsor
- Tris Pharma, Inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 31, 2014
- Completion date
- December 31, 2014
- Enrollment
- 108 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.